The determination of endocrine-disrupting properties with respect to human health should be based on human and/or animal evidence, therefore allowing for the identification of both known and presumed endocrine-disrupting substances.
Recital 4, Regulation (EU) 2017/2100
In forcesince 4 Sep 2017